When used alongside a balanced diet and exercise, GLP-1 and GLP-1/GIP medications can be a powerful tool for achieving lasting weight loss results
Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis
Eur J Drug Metab Pharmacokinet 41:839844
Across all these threads retatrutides tolerability limits, GLP-1s potential cancer signal, Novartiss explicit anti-me-too strategy, Bayers contrarian CGT commitment, and Chinas regulatory recalibration one principle holds: the companies winning in 2026 are those making deliberate bets on mechanisms and markets that others either cant stomach or havent yet noticed
Sustained elevation of glycolytic flux leads to lactate accumulation within myocardial tissue, and local microenvironmental acidification further suppresses mitochondrial function and weakens fatty acid oxidation capacity (71)
References: A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1